Cell line · CVCL_3936
OVCA429
Cancer cell line, Homo sapiens. Ovarian cystadenocarcinoma. 32 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. OVCA429. Cell lines, record CVCL_3936. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_3936
On this page
Cell line
As Cellosaurus gives it.
- Name
- OVCA429
- Accession
- CVCL_3936
- RRID
- RRID:CVCL_3936
- Synonyms
- OVCA 429, OvCA 429, OVCA-429, OVCAR-429, OVCAR 429, OVCAR429, OV429
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- Age unspecified
- Category
- Cancer cell line
- Diseases
- Ovarian cystadenocarcinoma (NCIt C5228)
- Derived from
- Ovary (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers32
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Extracellular vesicle lipidomics liquid biopsy reveals systemic and tumor microenvironment metabolic reprogramming in ovarian cancer. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting p300 Reverses Acidic Microenvironment-Induced PARP Inhibitor Resistance. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| BMAL2 is a druggable target for ovarian clear cell carcinoma (OCCC). | EMBO Mol Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Clinical and Functional Characterization of PDE1A as a Wnt/β-Catenin-Linked Biomarker of Progression and Platinum Resistance in Epithelial Ovarian Cancer. | Oncol Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Claudin-4 as a dual regulator of genome stability and immune evasion in high grade serous ovarian cancer. | Sci Rep | 2025 | Its Methods give the RRID and name the line | PubMed | |
| EMSY enhances glycolysis in ovarian cancer cells. | Eur J Med Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Selective Alanine Transporter Utilization Is a Therapeutic Vulnerability in ARID1A-Mutant Ovarian Cancer. | Cancer Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Claudin-4 Stabilizes the Genome via Nuclear and Cell-Cycle Remodeling to Support Ovarian Cancer Cell Survival. | Cancer Res Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| PubMed 39282307 | bioRxiv | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Claudin-4 Modulates Autophagy via SLC1A5/LAT1 as a Mechanism to Regulate Micronuclei. | Cancer Res Commun | 2024 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 32
See all 32 papersRelatives3
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | OVCA429/GFP | CVCL_JY92 | Cell lines | |
| Derived from it | OVCA429/T40 | CVCL_CZ99 | Cell lines | |
| Derived from it | OVCA429/TxT50 | CVCL_CZ98 | Cell lines |
Cell banks0
None in this release.
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_3936
GET https://conductscience.org/api/cell-lines/v1/CVCL_3936/papers?page=2